You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Sleep and sleep conditions

Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia

  • Technology appraisal guidance
  • Reference number: TA77
  • Published:  28 April 2004
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Clinical need and practice
  • 3 The technologies
  • 4 Evidence and interpretation
  • 5 Recommendations for further research
  • 6 Implications for the NHS
  • 7 Implementation and audit
  • 8 Appraisal Committee members and NICE project team
  • 9 Sources of evidence considered by the Committee
  • Appendix A Detail on criteria for audit of the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia
  • Update information

Update information

June 2018: The recommendations were updated because zaleplon no longer has a marketing authorisation in the UK.

ISBN: 978-1-4731-3039-5


Previous page Appendix A Detail on criteria for audit of the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia